There's no doubt that there will be plenty of choices. The drug is known to work on over 100 different types of cancer. I think the point is to isolate the cancers that exhibit the strongest reaction to Coramsine and pursue those through phase II. This will give the best chance of a positive (and potentially dramatic) outcome.
SBP
solbec pharmaceuticals limited
genentech up $11 billion, page-7
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)